Search
for
Sort by
Research 121–150 of 1000+
- Replacement with GABAergic steroid precursors restores the acute ethanol withdrawal profile in adrenalectomy/gonadectomy mice
- Androgen Action in the Ovary
- COVID-19 pandemic: what about the gonads?
- Androgens/Androgen Receptor in the Management of Skin Diseases
- Sex-Chromosome-Related Dimorphism in Steroidogenic Enzymes and Androgen Receptor in Response to Testosterone Treatment: An In Vitro Study on Human Primary Skeletal Muscle Cells
- Diffuse hair loss associated with hyperprolactinaemia: report of three cases
- Penis Endocrinology
- Redefining hormone resistance in prostate cancer
- Polycystic Ovary Syndrome
- The role of androgen and androgen receptor in skin-related disorders
- MENSTRUAL DISORDERS IN ADOLESCENTS
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- What is the Rationale for Androgen Therapy for Women?
- Skin and glucocorticoids: effects of local skin glucocorticoid impairment on skin homeostasis
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- Spironolactone in dermatology: uses in acne and beyond
- Neuroactive Steroids and Ethanol Exposure: Relevance to Ethanol Sensitivity and Alcohol Use Disorders Risk
- Treatment guidelines in adult women
- Effect of High Levels of Testosterone on Cardiovascular Risk in Polycystic Ovary Syndrome (PCOS)
- Management of teenagers with polycystic ovarian syndrome
- Testosterone in Women: Measurement and Therapeutic Use
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Development of polycystic ovary syndrome: involvement of genetic and environmental factors
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Hormonal Therapy for Acne
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*
- Obesity and the Polycystic Ovary Syndrome
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours